Key result
Review summarizes the role of endothelin-1 in cardiovascular physiology without reported clinical findings.
Why the study?
The physiological activities of endothelin-1 were not fully explored until the availability of specific ET-1 antagonists allowed investigation of its role in vascular tone adaptation.
This article reviews the molecular structure and biological activities of Endothelin-1 in cardiovascular physiology.
Endothelin-1 in cardiovascular physiology. MODESTI, PIETRO AMEDEO 1997 Abstract COPLEY LECTURE at the 9th European Conference on Clinical Haemorheology Abstract: Endothelin-1 (ET-1) is a 21 amino acid peptide endowed with a a powerful vasoconstrictor activity. The molecular structure and biological activities of endothelin were explored in several studies starting soon after its discovery in 1988, but only recently has the availability of specific ET-1 antagonists allowed its physiological activities to be explored. It is now becoming evident that circulating ET-1 plays a key role in the continuous adaptation of vessel wall tone, of both resistence and capacitance vessels. On the other hand, in addition to the ability to control blood flow, ET-1 synthesis is in turn controlled by blood flow itself, thus making the connection between ET-1 and peripheral circulation particularly close. This review will focus on recent knowledge about the physiological role of circulating endothelin-1.
No takes yet. Share an insight, caveat, or question.
Pietro Amedeo Modesti (1996) conducted a review in Cardiovascular physiology. Endothelin-1 was evaluated. No clinical findings or quantitative results are available in the provided repository metadata page for the paper on endothelin-1 in cardiovascular physiology.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: